JSCHX
Price
$39.70
Change
-$0.08 (-0.20%)
Updated
Jul 31 closing price
Net Assets
1.64B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

JSCHX vs VSCIX

JSCHX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
JSCHX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSCHX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. JSCHX (1.64B). VSCIX pays higher dividends than JSCHX: VSCIX (1.23) vs JSCHX (0.68). JSCHX was incepted earlier than VSCIX: JSCHX (8 years) vs VSCIX (29 years). JSCHX (0.76) is less costly to investors than VSCIX (0.03). JSCHX is a more actively managed with annual turnover of: 49.00 vs. VSCIX (17.00). VSCIX has a lower initial minimum investment than JSCHX: VSCIX (5000000) vs JSCHX (15000000). JSCHX (23.49) and VSCIX (22.58) have marching annual gain over last year. VSCIX return over 5 years is better than : 35.13 vs. JSCHX (19.07).
JSCHXVSCIXJSCHX / VSCIX
Total Expense Ratio0.740.032,467%
Annual Report Gross Expense Ratio0.760.032,533%
Fund Existence8 years29 years-
Gain YTD20.77914.591142%
Front LoadN/AN/A-
Min. Initial Investment150000005000000300%
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B189B1%
Annual Yield % from dividends0.681.2356%
Returns for 1 year23.4922.58104%
Returns for 3 years35.9543.4483%
Returns for 5 years19.0735.1354%
Returns for 10 yearsN/A156.07-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C